Bishop Hans Edgar
CEO & President at Juno Therapeutics, Inc.
- Sold, on record
- $30.1M
- Dollars the filings state
- Form 4 sales
- 8
- Latest Jan 16, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Juno Therapeutics, Inc.CEO & President
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Juno Therapeutics, Inc.Plan not statedDec 15, 2015 2015
Sold 91,500 shares at $45.72 ($4.2M)
Bishop Hans Edgar, CEO and President
Sold 3.3% of holdings ($127M position)2.7M shares leftFirst sale on recordFiling
- 2 Form 4 sale Juno Therapeutics, Inc.Plan not statedFeb 29, 2016 +76 days
Sold 90,750 shares at $35.32 ($3.2M)
Bishop Hans Edgar, Officer, Director
Sold 3.3% of holdings ($96.8M position)2.7M shares leftFiling
- 3 Form 4 sale Juno Therapeutics, Inc.Plan not statedJun 9, 2016 +101 days
Sold 90,750 shares at $46.42 ($4.2M)
Bishop Hans Edgar, CEO & President
Sold 3.4% of holdings ($126M position)2.6M shares leftFiling
- 4 Form 4 sale Juno Therapeutics, Inc.Plan not statedAug 31, 2016 +83 days
Sold 42,673 shares at $30.06 ($1.3M)
Bishop Hans Edgar, CEO & President
Sold 1.7% of holdings ($77M position)2.5M shares left0.5x usual sizeFiling
- 5 Form 4 sale Juno Therapeutics, Inc.Plan not statedSep 8, 2016 +8 days
Sold 23,042 shares at $30.06 ($693k)
Bishop Hans Edgar, CEO & President
Sold 0.9% of holdings ($76.4M position)2.5M shares left0.3x usual sizeFiling
- 6 Form 4 sale Juno Therapeutics, Inc.Plan not statedSep 21, 2016 +13 days
Sold 84,035 shares at $30.28 ($2.5M)
Bishop Hans Edgar, CEO & President
Sold 3.3% of holdings ($76.6M position)2.4M shares left0.9x usual sizeFiling
- 7 Form 4 sale Juno Therapeutics, Inc.Plan not statedSep 27, 2016 +6 days
Sold 44,000 shares at $33.00 ($1.5M)
Bishop Hans Edgar, CEO & President
Sold 1.8% of holdings ($82.2M position)2.4M shares left0.5x usual sizeFiling
- 8 Form 4 sale Juno Therapeutics, Inc.UnusualJan 16, 2018 +476 days
Sold 270,250 shares at $46.17 ($12.5M)
Bishop Hans Edgar, CEO & President
Sold 9.7% of holdings ($128M position)2.5M shares left4.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2018 | Jan 18, 2018 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 270,250 | $12.5M | 9.7% | Unusual | SEC |
| Sep 27, 2016 | Sep 29, 2016 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 44,000 | $1.5M | 1.8% | Plan not stated | SEC |
| Sep 21, 2016 | Sep 21, 2016 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 84,035 | $2.5M | 3.3% | Plan not stated | SEC |
| Sep 8, 2016 | Sep 9, 2016 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 23,042 | $693k | 0.9% | Plan not stated | SEC |
| Aug 31, 2016 | Sep 2, 2016 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 42,673 | $1.3M | 1.7% | Plan not stated | SEC |
| Jun 9, 2016 | Jun 13, 2016 | Juno Therapeutics, Inc. | CEO & President | Form 4 sale | 90,750 | $4.2M | 3.4% | Plan not stated | SEC |
| Feb 29, 2016 | Mar 2, 2016 | Juno Therapeutics, Inc. | Officer, Director | Form 4 sale | 90,750 | $3.2M | 3.3% | Plan not stated | SEC |
| Dec 15, 2015 | Dec 17, 2015 | Juno Therapeutics, Inc. | CEO and President | Form 4 sale | 91,500 | $4.2M | 3.3% | Plan not stated | SEC |